Drugs were approved in the U.S. 469 days earlier (on average) than in Canada.
Protracted lockdowns slowly strangle the economic and social life of the country.
Planned changes would likely result in fewer new and innovative drugs available to Canadians.
New clinical trials registered with Health Canada fell by more than 52 per cent.
Review board’s new reference countries have more limited access to new and innovative drugs.